colorectal cancer
Conditions
Interventions
A piece of dried interceed which is 3-5mm larger than the surgery site will be placed to prevent adhesion just before abdominal closure of the laparoscopic surgery.
Normal laparoscopic surgery (withou
Sponsors
Kitasato University Department of Surgery
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who aged over 20 years old Patients who adapt for the laparoscopic surgery of the lower gastrointestinal Patients who have intention of the participation in this study and agree to sign on the written informed consent Patients who are judged as appropriate using interceed by a doctor
Exclusion criteria
Exclusion criteria: Patients who have persistence of cancer macroscopically Patients who are given anticancer drugs intraperitoneally Patients who have sever hapatic damage, kidney damage, heart disease and infection desease Patients who will be used other anti-adhesion methods in both groups including the non-use interceed Patients who will be used over the site that has been soaked in blood Patients who will be used over the contaminated or infected wound Patients who have history of severe drug allergy Patients who have history of oxidized regenerated cellulose allergy Patients who are judged inappropriate by a doctor
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Frequency of serious adverse event within 30 days from surgery. | — |
Secondary
| Measure | Time frame |
|---|---|
| Frequency of serious adverse event within 6 months after surgery. Frequency of infection of the surgical site within 30 days and 6 months after surgery. Frequency of adhesive ileus within 30 days and 6 months after surgery. The use of evaluation of the intercede during surgery. | — |
Countries
Japan
Outcome results
None listed